flumazenil has been researched along with Age-Related Macular Degeneration in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Acar, N | 1 |
Merle, BMJ | 1 |
Ajana, S | 1 |
He, Z | 1 |
Grégoire, S | 1 |
Hejblum, BP | 1 |
Martine, L | 1 |
Buaud, B | 1 |
Bron, AM | 1 |
Creuzot-Garcher, CP | 1 |
Korobelnik, JF | 1 |
Berdeaux, O | 1 |
Jacqmin-Gadda, H | 1 |
Bretillon, L | 1 |
Delcourt, C | 1 |
1 other study available for flumazenil and Age-Related Macular Degeneration
Article | Year |
---|---|
Predicting the retinal content in omega-3 fatty acids for age-related macular-degeneration.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cholesterol Esters; Dietary Supplements; Discriminant | 2021 |